Dafna Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $2.54 Million - $4.92 Million	-157,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $487,224 - $1.03 Million	39,741 Added 33.89%	157,000 $2.61 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $981,457 - $2.41 Million	117,259	117,259 $2.41 Million

131

34.9M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $215M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.